Atlas Trials

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00798603 · COMPLETED

Trial details

NCT number
NCT00798603
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2008-12-01
Primary completion
2011-03-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.